Mostrar el registro sencillo del ítem
Effects of Exercise and Physical Activity Levels on Vaccination Efficacy: A Systematic Review and Meta-Analysis
| dc.creator | Dinas P.C., Koutedakis Y., Ioannou L.G., Metsios G., Kitas G.D. | en |
| dc.date.accessioned | 2023-01-31T07:56:54Z | |
| dc.date.available | 2023-01-31T07:56:54Z | |
| dc.date.issued | 2022 | |
| dc.identifier | 10.3390/vaccines10050769 | |
| dc.identifier.issn | 2076393X | |
| dc.identifier.uri | http://hdl.handle.net/11615/73364 | |
| dc.description.abstract | Objective: We examined whether different intensities of exercise and/or physical activity (PA) levels affected and/or associated with vaccination efficacy. Methods: A systematic review and meta-analysis was conducted and registered with PROSPERO (CRD42021230108). The PubMed, EMBASE, Cochrane Library (trials), SportDiscus, and CINAHL databases were searched up to January 2022. Results: In total, 38 eligible studies were included. Chronic exercise increased influenza antibodies (standardized mean difference (SMD) = 0.49, confidence interval (CI) = 0.25–0.73, Z = 3.95, I2 = 90%, p < 0.01), which was mainly driven by aerobic exercise (SMD = 0.39, CI = 0.19–0.58, Z = 3.96, I2 = 77%, p < 0.01) as opposed to combined (aerobic + resistance; p = 0.07) or other exercise types (i.e., taiji and qigong, unspecified; p > 0.05). PA levels positively affected antibodies in response to influenza vaccination (SMD = 0.18, CI = 0.02–0.34, Z = 2.21, I2 = 76%, p = 0.03), which was mainly driven by high PA levels compared to moderate PA levels (Chi2 = 10.35, I2 = 90.3%, p < 0.01). Physically active individuals developed influenza antibodies in response to vaccination in >4 weeks (SMD = 0.64, CI = 0.30–0.98, Z = 3.72, I2 = 83%, p < 0.01) as opposed to <4 weeks (p > 0.05; Chi2 = 13.40, I2 = 92.5%, p < 0.01) post vaccination. Conclusion: Chronic aerobic exercise or high PA levels increased influenza antibodies in humans more than vaccinated individuals with no participation in exercise/PA. The evidence regarding the effects of exercise/PA levels on antibodies in response to vaccines other than influenza is extremely limited. © 2022 by the authors. Licensee MDPI, Basel, Switzerland. | en |
| dc.language.iso | en | en |
| dc.source | Vaccines | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85130353838&doi=10.3390%2fvaccines10050769&partnerID=40&md5=7fcff18ee167939d1e616b9d7410a57d | |
| dc.subject | antibody | en |
| dc.subject | influenza vaccine | en |
| dc.subject | interleukin 6 | en |
| dc.subject | Pneumococcus vaccine | en |
| dc.subject | vaccine | en |
| dc.subject | adult | en |
| dc.subject | aged | en |
| dc.subject | autoimmune disease | en |
| dc.subject | body mass | en |
| dc.subject | Cochrane Library | en |
| dc.subject | coronary artery disease | en |
| dc.subject | data extraction | en |
| dc.subject | data synthesis | en |
| dc.subject | Embase | en |
| dc.subject | exercise | en |
| dc.subject | female | en |
| dc.subject | human | en |
| dc.subject | influenza vaccination | en |
| dc.subject | male | en |
| dc.subject | Medline | en |
| dc.subject | meta analysis | en |
| dc.subject | physical activity | en |
| dc.subject | quality control | en |
| dc.subject | randomized controlled trial (topic) | en |
| dc.subject | Review | en |
| dc.subject | rheumatic disease | en |
| dc.subject | systematic review | en |
| dc.subject | vaccination | en |
| dc.subject | MDPI | en |
| dc.title | Effects of Exercise and Physical Activity Levels on Vaccination Efficacy: A Systematic Review and Meta-Analysis | en |
| dc.type | other | en |
Ficheros en el ítem
| Ficheros | Tamaño | Formato | Ver |
|---|---|---|---|
|
No hay ficheros asociados a este ítem. |
|||
